Sign In
Buy COR
$303.44
+0.98 (+0.324%)
At Close: Jul 10, 2026
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
01:09pm, Monday, 06'th Jul 2026
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
04:30pm, Wednesday, 01'st Jul 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the openi
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
01:50pm, Thursday, 18'th Jun 2026
COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
11:36am, Thursday, 18'th Jun 2026
COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
09:00am, Thursday, 18'th Jun 2026
Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
09:56am, Wednesday, 17'th Jun 2026
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, VRT, CLS and COR are some such stocks.
Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician Practices
08:00am, Wednesday, 17'th Jun 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced a multi-site pilot of its enhanced Nucleus® inventory management solution, designed to help spe
Cencora Announces Samantha Hammock as Chief Human Resources Officer
04:15pm, Monday, 15'th Jun 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire f
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
10:45am, Tuesday, 09'th Jun 2026
The shares of both stocks are down so far this year. Stevanato is benefiting from the need for GLP-1 injectables.
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
03:16pm, Friday, 05'th Jun 2026
COR bets on MSOs, specialty logistics and AI tools to deepen ties beyond distribution???even as GLP-1 mix and pricing swings cloud results.
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 05'th Jun 2026
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know
10:57am, Friday, 05'th Jun 2026
The mean of analysts' price targets for Cencora (COR) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
10:00am, Thursday, 04'th Jun 2026
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact Dan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
04:57pm, Tuesday, 02'nd Jun 2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR). Such investors are advised
Cencora to Support U.S. Distribution of Kite's CAR T-Cell Therapies
08:00am, Tuesday, 02'nd Jun 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora today announced an agreement with Kite, a Gilead Company, to support the distribution of Kite's U.S. Food and Drug Administration (FDA)-approved CAR T-cell
